PRICES include / exclude VAT
Homepage>BS Standards>11 HEALTH CARE TECHNOLOGY>11.100 Laboratory medicine>11.100.10 In vitro diagnostic test systems>BS EN ISO 20186-1:2019 Molecular in vitro diagnostic examinations. Specifications for pre-examination processes for venous whole blood Isolated cellular RNA
Sponsored link
immediate downloadReleased: 2019-04-02
BS EN ISO 20186-1:2019 Molecular in vitro diagnostic examinations. Specifications for pre-examination processes for venous whole blood Isolated cellular RNA

BS EN ISO 20186-1:2019

Molecular in vitro diagnostic examinations. Specifications for pre-examination processes for venous whole blood Isolated cellular RNA

Format
Availability
Price and currency
English Secure PDF
Immediate download
249.60 EUR
You can read the standard for 1 hour. More information in the category: E-reading
Reading the standard
for 1 hour
24.96 EUR
You can read the standard for 24 hours. More information in the category: E-reading
Reading the standard
for 24 hours
74.88 EUR
English Hardcopy
In stock
249.60 EUR
Standard number:BS EN ISO 20186-1:2019
Pages:30
Released:2019-04-02
ISBN:978 0 580 90876 7
Status:Standard
DESCRIPTION

BS EN ISO 20186-1:2019


This standard BS EN ISO 20186-1:2019 Molecular in vitro diagnostic examinations. Specifications for pre-examination processes for venous whole blood is classified in these ICS categories:
  • 11.100.10 In vitro diagnostic test systems

This document gives guidelines on the handling, storage, processing and documentation of venous whole blood specimens intended for cellular RNA examination during the pre-examination phase before a molecular examination is performed. This document covers specimens collected in venous whole blood collection tubes.

This document is applicable to any molecular in vitro diagnostic examination performed by medical laboratories. It is also intended to be used by laboratory customers, in vitro diagnostics developers and manufacturers, biobanks, institutions and commercial organizations performing biomedical research, and regulatory authorities.

Different dedicated measures are taken for stabilizing blood cell free circulating RNA and RNA in exosomes circulating in blood. These are not described in this document.

Different dedicated measures are taken for collecting, stabilizing, transporting and storing capillary blood as well as for collecting and storing blood by paper based technologies or other technologies generating dried blood. These are not described in this document.

This document does not cover the isolation of specific blood cells and subsequent isolation of cellular RNA therefrom.

RNA in pathogens present in blood is not covered by this document.